Prescient brings deep scientific and strategic understanding to partner with medical VPs and directors at a portfolio planning and evidence-generation strategy level. With this expertise, we can provide organizational development to build future-proofed medical affairs capabilities.Talk to our team
Shaping strategies and building capabilities
Expertise, experience and evidence. From development to launch.
The breadth and depth of our medical know-how enables us to provide strategic and organization support right across your asset portfolio – from molecule development to launch. At the heart of this support is our expertise, experience and evidence.
Our medical affairs specialists have extensive experience in partnering with clients to develop medical strategies that unlock the full potential of your biopharma innovation. Our depth of expertise stretches across many therapeutic areas: oncology, haematology, immunology, neurosciences, infectious diseases and rare diseases. We combine this scientific understanding with business-minded thinking. From day one, we understand not only your molecule but its potential.
We have the medical, scientific and strategic experience needed to successfully partner with medical VPs and directors. We do so at both a portfolio planning and evidence-generation strategy level. With our depth of understanding, we can shape the organizational development required to unlock the full potential of your medical affairs capabilities. We’ll ensure you’re designed and constructed as a world-class medical affairs function – ready to guide the future of your organization.
Evidence generation is at the forefront of our approach to ensure you achieve not just the regulatory criteria, but you also achieve access and successful commercialization. Our team is steeped in content knowledge to fuel key strategic discussions and ensure that disease nuances, mechanistic options and therapeutic trends are fully incorporated. We ensure that strategy is developed in the medical and scientific context to unlock the full potential of your innovation.
How We Help
Diverse perspectives. Delivering progress.
Three diverse perspectives come together to bridge your clinical and commercial strategies, setting a clear direction for your asset.
We understand your molecule’s potential from the start. We have deep expertise in oncology, hematology, immunology, neurosciences, infectious diseases and rare diseases. Our team’s content knowledge fuels key strategic discussions and ensures that disease nuances, mechanistic options and therapeutic trends are fully explored.
Providing medical and scientific context to the overall design and management of a portfolio is critical and requires the medical team to play a lead role. We translate your science into strategic direction and help you effectively embed and communicate your tactical execution plans, all in a way that is well understood by your cross-functional colleagues.
Medical affairs experts
We are a group of medical affairs specialists. We thrive on partnering with clients to develop medical strategies that optimally demonstrate the value of their science and ultimately improve patient lives.